Ebola outbreak coincides with massive vaccine campaign
Oct 4, 2014 15:32:47 GMT -5
Post by schwartzie on Oct 4, 2014 15:32:47 GMT -5
VRM: Special Report
—————————————————————————————————————–—-
The recent Ebola outbreak in Africa coincides with a massive Meningitis Vaccine campaign targeting over 100 million Africans; notably including all four African countries (Guinea, Nigeria, Liberia, Sierra Leone) caught in the epicentre of the viral spread.
The cost-effective vaccine, MenAfriVac®,(less than US$0.50 per dose) was “kept outside the cold chain for up to four days at up to 40°C”.
Vaccine Resistance Movement is investigating the link between this extremely toxic experimental vaccine and the sudden surge in cases of Ebola.
Symptoms of ‘Acute fulminating Meningococcal Septicemia’, a virulent form of bacterial meningitis (marked by extreme vomiting, hemorrhaging – excessive bleeding around the eyes & mouth, severe blackish bruising on the arms & legs), closely resemble those seen in Ebola victims.
Why has the Ebola virus suddenly erupted in a region of Africa known as the “Meningitis Belt”? Because the WHO & CDC are deliberately trying to cover up their bloody tracks once again.
This supposed outbreak of Ebola bares all the hallmarks of a rarified, virulent strain of bacterial Meningitis, ‘Acute fulminating Meningococcal Septicemia’, also known as ‘Waterhouse-Friderichsen Syndrome’. Another case of a dangerous, untested vaccine triggering a tsunami of viral mutations – in impoverished regions.
Waterhouse-Friderichsen Syndrome: ‘The prodromal symptoms were similar to those encountered in any respiratory infection, consisting of headache, chilly sensations, muscular pains and malaise. The onset of the bacteremia was sudden and dramatic. The most striking features were the profound shock and the petechial eruption, which in the course of a few hours became purpuric…This condition gradually progressed until numerous coarse, bubbling rales could be heard over both lung fields. With the appearance of frank pulmonary edema terminally, the patient lapsed into coma and died shortly thereafter.‘
Ebola Virus: ‘Generally, the abrupt onset of Ebola haemorrhagic fever follows an incubation period of 2–21 days (mean 4–10) and is characterised by fever, chills, malaise, and myalgia. The subsequent signs and symptoms indicate multisystem involvement and include systemic (prostration), gastrointestinal (anorexia, nausea, vomiting, abdominal pain, diarrhoea), respiratory (chest pain, shortness of breath, cough, nasal discharge), vascular (conjunctival injection, postural hypotension, oedema), and neurological (headache, confusion, coma) manifestations.
Haemorrhagic manifestations arise during the peak of the illness and include petechiae, ecchymoses, uncontrolled oozing from venepuncture sites, mucosal haemorrhages, and post-mortem evidence of visceral haemorrhagic effusions. A macropapular rash associated with varying severity of erythema and desquamate can often be noted by day 5–7 of the illness; this symptom is a valuable differential diagnostic feature and is usually followed by desquamation in survivors. Abdominal pain is sometimes associated with hyperamylasaemia and true pancreatitis. In later stages, shock, convulsions, severe metabolic disturbances, and, in more than half the cases, diffuse coagulopathy supervene.‘ Heinz Feldmann, MD and Thomas W Geisbert, PhD, The Lancet
Even the CDC Director admits they are baffled by the unprecedented concentration of cases,
‘For more than four decades, Ebola virus had only been diagnosed in Central or Eastern Africa. Then late this past March, the first cases of Ebola began appearing in a surprising part of the continent. The outbreak in Guinea was the first sign that the virus had made the jump across the continent. Ebola then spread quickly to Sierra Leone and Liberia, and then to Nigeria.‘ Tom Frieden, MD, MPH, Director, US Centers for Disease Control and Prevention, Atlanta, Georgia
link
—————————————————————————————————————–—-
The recent Ebola outbreak in Africa coincides with a massive Meningitis Vaccine campaign targeting over 100 million Africans; notably including all four African countries (Guinea, Nigeria, Liberia, Sierra Leone) caught in the epicentre of the viral spread.
The cost-effective vaccine, MenAfriVac®,(less than US$0.50 per dose) was “kept outside the cold chain for up to four days at up to 40°C”.
Vaccine Resistance Movement is investigating the link between this extremely toxic experimental vaccine and the sudden surge in cases of Ebola.
Symptoms of ‘Acute fulminating Meningococcal Septicemia’, a virulent form of bacterial meningitis (marked by extreme vomiting, hemorrhaging – excessive bleeding around the eyes & mouth, severe blackish bruising on the arms & legs), closely resemble those seen in Ebola victims.
Why has the Ebola virus suddenly erupted in a region of Africa known as the “Meningitis Belt”? Because the WHO & CDC are deliberately trying to cover up their bloody tracks once again.
This supposed outbreak of Ebola bares all the hallmarks of a rarified, virulent strain of bacterial Meningitis, ‘Acute fulminating Meningococcal Septicemia’, also known as ‘Waterhouse-Friderichsen Syndrome’. Another case of a dangerous, untested vaccine triggering a tsunami of viral mutations – in impoverished regions.
Waterhouse-Friderichsen Syndrome: ‘The prodromal symptoms were similar to those encountered in any respiratory infection, consisting of headache, chilly sensations, muscular pains and malaise. The onset of the bacteremia was sudden and dramatic. The most striking features were the profound shock and the petechial eruption, which in the course of a few hours became purpuric…This condition gradually progressed until numerous coarse, bubbling rales could be heard over both lung fields. With the appearance of frank pulmonary edema terminally, the patient lapsed into coma and died shortly thereafter.‘
Ebola Virus: ‘Generally, the abrupt onset of Ebola haemorrhagic fever follows an incubation period of 2–21 days (mean 4–10) and is characterised by fever, chills, malaise, and myalgia. The subsequent signs and symptoms indicate multisystem involvement and include systemic (prostration), gastrointestinal (anorexia, nausea, vomiting, abdominal pain, diarrhoea), respiratory (chest pain, shortness of breath, cough, nasal discharge), vascular (conjunctival injection, postural hypotension, oedema), and neurological (headache, confusion, coma) manifestations.
Haemorrhagic manifestations arise during the peak of the illness and include petechiae, ecchymoses, uncontrolled oozing from venepuncture sites, mucosal haemorrhages, and post-mortem evidence of visceral haemorrhagic effusions. A macropapular rash associated with varying severity of erythema and desquamate can often be noted by day 5–7 of the illness; this symptom is a valuable differential diagnostic feature and is usually followed by desquamation in survivors. Abdominal pain is sometimes associated with hyperamylasaemia and true pancreatitis. In later stages, shock, convulsions, severe metabolic disturbances, and, in more than half the cases, diffuse coagulopathy supervene.‘ Heinz Feldmann, MD and Thomas W Geisbert, PhD, The Lancet
Even the CDC Director admits they are baffled by the unprecedented concentration of cases,
‘For more than four decades, Ebola virus had only been diagnosed in Central or Eastern Africa. Then late this past March, the first cases of Ebola began appearing in a surprising part of the continent. The outbreak in Guinea was the first sign that the virus had made the jump across the continent. Ebola then spread quickly to Sierra Leone and Liberia, and then to Nigeria.‘ Tom Frieden, MD, MPH, Director, US Centers for Disease Control and Prevention, Atlanta, Georgia
link
